HELLO CHINA

INDUSTRY CLUSTER · Biomedicine

Jiading Precision Medicine Cluster, Shanghai

Samples, diagnostic reagents and cell-processing materials connect medical testing, molecular analysis, process scale-up and clinical translation in Jiading, producing diagnostic services, cell-therapy programmes and research outputs for healthcare institutions, research teams and health-management settings.

Formation and regional foundations

Jiading Precision Medicine Cluster, Shanghai appears in authority list dated 2024, and each named entity uses its corresponding public record.

The authority list uses the name Jiading Precision Medicine Cluster, Shanghai. A working review can begin with compliant samples and sample preparation.

Core geography: Jiading Precision Medicine Park and life-science sites in Nanxiang and Anting

Jiading Precision Medicine Cluster, Shanghai operating-chain map

Six supply-and-demand connections in Jiading Precision Medicine Cluster, Shanghai

The links for Jiading Precision Medicine Cluster, Shanghai show only a project-scoping sequence, moving from compliant samples toward delivery conditions.

  • compliant samples — Input review for Jiading Precision Medicine Cluster, Shanghai centres on compliant samples and checks material identity, compliance documents, lot and storage or transport conditions before work begins.
  • sample preparation — Operations for Jiading Precision Medicine Cluster, Shanghai follow sample preparation and record controlled steps, validation status, environmental conditions and deviation handling at each handoff.
  • medical test results — Output scope for Jiading Precision Medicine Cluster, Shanghai covers medical test results, with intended scope, test results, release documents and storage or transport requirements defined separately.
  • hospitals — Demand for Jiading Precision Medicine Cluster, Shanghai comes from hospitals, with specifications and delivery terms checked against research, production, clinical or regulatory use conditions.
  • control of sample custody — Acceptance for Jiading Precision Medicine Cluster, Shanghai follows control of sample custody, with measurement and retest results linked to a controlled lot or validated revision.
  • molecular diagnostics delivery arrangements — Delivery for Jiading Precision Medicine Cluster, Shanghai follows molecular diagnostics delivery arrangements and checks release status, temperature control, protection, handover and traceability files.

01 · Jiading Precision Medicine Cluster, Shanghai: Inputs and inbound terms

This chapter reviews input mix and inbound conditions for Jiading Precision Medicine Cluster, Shanghai.

Input mix: compliant samples, diagnostic reagents, cell-processing consumables, culture media and clinical research needs.

For the path from compliant samples through sample preparation to medical test results, first check material identity, compliance documents, lot and storage or transport conditions, retain practical samples and verify sites, equipment or services through records and field conditions.

In Shanghai, physical inputs such as compliant samples carry a lot trail through packaging, transport and traceability records, while sites, equipment or services retain their own reference numbers.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, material identity, compliance documents, lot and storage or transport conditions should be explicit.

02 · Jiading Precision Medicine Cluster, Shanghai: Operations and handoffs

This chapter reviews production stages and engineering interfaces for Jiading Precision Medicine Cluster, Shanghai.

Operating sequence: sample preparation, molecular analysis, cell processing, quality testing, process scale-up and clinical translation.

After a change to sample preparation, reassess control of sample custody and update records for controlled steps, validation status, environmental conditions and deviation handling.

Before sample preparation in Shanghai moves to medical test results, use a limited trial, test harvest or stage result to confirm the output boundary.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, equipment, software versions and accountable owners should be explicit.

03 · Jiading Precision Medicine Cluster, Shanghai: Outputs and acceptance

This chapter reviews output forms and acceptance measures for Jiading Precision Medicine Cluster, Shanghai.

Output range: medical test results, companion diagnostic services, cell-product processes and translational research outputs.

Acceptance of medical test results from sample preparation in Shanghai should specify reproducible samples, methods, environments and decision rules.

Review of medical test results separately covers registration or filing boundaries, specifications, lot records, storage and transport conditions, and user support.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, specifications, test environments and delivery documents should be explicit.

04 · Jiading Precision Medicine Cluster, Shanghai: Demand and purchasing

This chapter reviews demand side and purchasing routes for Jiading Precision Medicine Cluster, Shanghai.

Demand side: hospitals, medical laboratories, biotechnology companies, research teams and health-management providers.

In Shanghai, demand from hospitals can be separated by research, production, clinical or regulatory use conditions, then matched to the conditions for medical test results.

An inquiry from hospitals for medical test results should state acceptance and delivery terms as well as volume and price.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, use case, volume range and acceptance owner should be explicit.

05 · Jiading Precision Medicine Cluster, Shanghai: Named entities

The three named entities for Jiading Precision Medicine Cluster, Shanghai each link to their own public material.

Shanghai Zhiben Medical Laboratory Co., Ltd: Provides molecular pathology and medical laboratory services.

Sino-FuNoGen Biotechnology (Shanghai) Co., Ltd: Develops cell technologies and translation processes.

Shanghai JunSai Biotechnology Co., Ltd: Advances cell-therapy research, process scale-up and clinical translation.

  • The three named entities for Jiading Precision Medicine Cluster, Shanghai use only relationships directly stated in their own material.

06 · Jiading Precision Medicine Cluster, Shanghai: Quality and records

This chapter reviews quality review and technical files for Jiading Precision Medicine Cluster, Shanghai.

Acceptance focus: control of sample custody, method validation, sterility, batch release and data integrity.

When operating conditions for sample preparation in Shanghai change, reassess control of sample custody and update controlled steps, validation status, environmental conditions and deviation handling.

After release of medical test results from sample preparation in Shanghai, set retesting, exception isolation and correction deadlines so responsibility remains traceable to a controlled lot or validated revision.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, samples, test conditions and decision rules should be explicit.

07 · Jiading Precision Medicine Cluster, Shanghai: Delivery and site handover

This chapter reviews transport, delivery and site handover for Jiading Precision Medicine Cluster, Shanghai.

Samples and reagents move under specified temperatures, while cell materials use timed handling and end-to-end records.

When delivery of medical test results from sample preparation in Shanghai spans several traceable units or service stages, every deliverable should link back to its record.

Delivery of medical test results to hospitals keeps packaging integrity, lot labels, storage temperature, transit time and arrival checks linked.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, packaging, temperature, humidity, shock protection and arrival checks should be explicit.

08 · Jiading Precision Medicine Cluster, Shanghai: Engagement and due diligence

This chapter reviews engagement sequence and due-diligence list for Jiading Precision Medicine Cluster, Shanghai.

Verify institutional qualifications, ethics approvals, sample consent, assay performance, data protection and clinical boundaries.

When checking entities including Shanghai Zhiben Medical Laboratory Co., Ltd, cluster designation does not prove performance; before quoting medical test results, assign responsibility for control of sample custody and molecular diagnostics delivery arrangements.

In Jiading Precision Medicine Park and life-science sites in Nanxiang and Anting, an engagement for medical test results from sample preparation can begin with a small lot, pilot or stage deliverable before capacity, lead time and longer arrangements are set.

  • Before Jiading Precision Medicine Cluster, Shanghai moves into execution, separate conclusions on regional designation and company capability should be explicit.

Sources and reading notes

Jiading Precision Medicine Cluster, Shanghai follows the name used in the authority list, records the three companies only by complete legal name and directly stated relationship, and leaves capacity, pricing and engagement terms for separate checks.

  • Jiading Precision Medicine Cluster, Shanghai is the cluster name used in the 2024 authority list.
  • The corresponding public record states this relationship for Shanghai Zhiben Medical Laboratory Co., Ltd: Jiading | Provides molecular pathology and medical laboratory services.
  • The corresponding public record states this relationship for Sino-FuNoGen Biotechnology (Shanghai) Co., Ltd: Jiading | Develops cell technologies and translation processes.
  • The corresponding public record states this relationship for Shanghai JunSai Biotechnology Co., Ltd: Jiading | Advances cell-therapy research, process scale-up and clinical translation.

Related companies

These companies have a locally relevant industry role supported by public information. Order is not a ranking, inclusion does not imply authorization, partnership or endorsement, and Hello China does not participate in or guarantee transactions.

A company may request a free correction or removal through the formal channel if its record is inaccurate or it does not wish to be shown. Do not send business licences, authorization letters or other sensitive files through insecure channels.

Sources

Use the original publishers to check dates, scope and definitions; public material is not a transaction guarantee.